Michael "Mike" Albert, MD (@michaelalbertmd) 's Twitter Profile
Michael "Mike" Albert, MD

@michaelalbertmd

Co-Founder, Chief Medical Officer @accomplishhlth | Obesity & Cardiometabolic Medicine | Clinical Incretinology | Healthcare Futurist

ID: 1010678065398087681

linkhttps://linktr.ee/MichaelAlbertMD calendar_today24-06-2018 00:16:43

21,21K Tweet

14,14K Takipçi

1,1K Takip Edilen

Michael "Mike" Albert, MD (@michaelalbertmd) 's Twitter Profile Photo
Michael "Mike" Albert, MD
@michaelalbertmd

23 days ago

🚨BREAKING: FDA grants accelerated approval to Wegovy (semaglutide 2.4 mg injection) for treating adults with non‑cirrhotic metabolic dysfunction‑associated steatohepatitis (MASH) with moderate to advanced liver fibrosis - - - A Fourth Indication for Wegovy Wegovy’s FDA-approved

🚨BREAKING: FDA grants accelerated approval to Wegovy (semaglutide 2.4 mg injection) for treating adults with non‑cirrhotic metabolic dysfunction‑associated steatohepatitis (MASH) with moderate to advanced liver fibrosis - - - A Fourth Indication for Wegovy Wegovy’s FDA-approved